Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Assets Average (2016 - 2025)

Perspective Therapeutics' Assets Average history spans 14 years, with the latest figure at $302.8 million for Q3 2025.

  • For Q3 2025, Assets Average fell 22.07% year-over-year to $302.8 million; the TTM value through Sep 2025 reached $302.8 million, down 22.07%, while the annual FY2024 figure was $219.5 million, 181.44% up from the prior year.
  • Assets Average for Q3 2025 was $302.8 million at Perspective Therapeutics, down from $320.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $388.5 million in Q3 2024 and bottomed at $43.4 million in Q1 2021.
  • The 5-year median for Assets Average is $104.2 million (2023), against an average of $167.2 million.
  • The largest annual shift saw Assets Average skyrocketed 731.89% in 2021 before it dropped 22.07% in 2025.
  • A 5-year view of Assets Average shows it stood at $68.0 million in 2021, then decreased by 11.28% to $60.3 million in 2022, then skyrocketed by 72.77% to $104.2 million in 2023, then surged by 251.35% to $366.1 million in 2024, then decreased by 17.3% to $302.8 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Assets Average are $302.8 million (Q3 2025), $320.0 million (Q2 2025), and $335.2 million (Q1 2025).